The Local Government Association, representing councils in England and Wales, has stated that current laws only permit a 5% tax rate on "products designed to help people quit smoking". The UK government has indicated that, given existing scientific evidence showing that e-cigarettes can indeed assist with smoking cessation, it intends to lower the VAT on e-cigarette products to 5%.
David Fothergill, Chairman of the LGA Community Wellbeing Board, stated that there is growing evidence to support the use of e-cigarettes and other specialized forms of smoking cessation in helping people quit smoking. This reduces the risk of harmful diseases and deaths, as well as alleviating other pressures on healthcare services.
At the same time, in October of last year, the regulatory body for pharmaceutical and healthcare products announced that any approved electronic cigarette products would only be prescribed by doctors. "Whether it is the COVID-19 vaccine we have developed or the innovative public health measures we have implemented to reduce the risk of serious illnesses for people, this country remains a global leader in the healthcare field," said Health Secretary Sajid Javid.
Opening the door to NHS-approved e-cigarettes could potentially address the significant disparities in smoking rates nationwide and help people quit smoking in any location or circumstance, Javid said. He recently faced criticism for suggesting a ban on smoking outside of pubs and restaurants.
A recent survey has revealed that over a third of the public support the provision of e-cigarettes on the NHS. The survey by GoSmokeFree.co.uk questioned 1,200 respondents in order to gauge their opinions on this development. Considering the smoking cessation potential of these products, 35% of people approve of them being available on prescription. With regards to the risks associated with conventional tobacco cigarettes, a further 38% of people stated that they believe smoking should be banned altogether, whilst 45% feel that local anti-smoking laws are not strict enough.
Statement:
This article is compiled from third-party information and is provided only for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS and we are unable to confirm the authenticity and accuracy of the content. The translation of this article is solely for industry exchange and research purposes.
Due to limitations in translation ability, the accuracy of the translated article may differ slightly from the original version. Please refer to the original article for precise wording.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
